Dr. Anuj Goel
Chief Development Officer, Biocon
Dr. Anuj Goel is the Chief Development Officer (CDO) at Biocon, leading all Research & Development functions; R&D-CMC, Clinical Development & Medical Affairs and Regulatory Affairs.
Anuj is a Biocon veteran, having joined the company in 1996 to start the process development group in R&D. He has had diverse experience working on solid state fermentation, deep tank enzyme production, fermentation of small molecules metabolites and recombinant proteins and peptides using bacterial, fungal and mammalian cell lines. He served as the CDO of Biocon Biologics between October 2024 and March 2026.
Anuj has been instrumental in transforming Biocon’s development labs into premier facilities that drive R&D excellence, fostering innovation and growth. Over the years, his team has developed technology for statins, immunosuppressants, recombinant proteins, insulins and monoclonal antibodies.
He brings extensive experience and comprehensive organizational leadership, having served as a bench scientist, project manager, portfolio leader, function head and has led the R&D-CMC department.
Anuj has mentored many emerging leaders at Biocon Biologics, demonstrating his exceptional leadership skills. He has also been a key stakeholder in advancing the biosimilars portfolio over the years through collaborations with partners and stakeholders.
Anuj holds a PhD in Biotechnology from Pune University and has more than 15 publications and patents to his credit.
